Development of postcastration syndrome and corrective effect of xenon in exponential dose regimen in young patients with gynecological cancers

Purpose of the study. Investigation of possible optimization of treatment in patients with breast cancer and cervical cancer with low-dose xenon therapy.

Patients and methods. The study included 156 patients with pT1В2N0M0 cervical cancer (CC) and pT2N1M0 breast cancer (BC) of the reproductive age (29–45 years) after radical treatment, including forced surgical castration in hormone-positive breast cancer with concomitant gynecological pathology. Since the formation of pathological syndromes, 1 cycle (5 sessions) of low-dose xenon inhalation therapy (XT) was performed, with an algorithm for xenon dose calculation and exposure according to the exponential pattern of decreasing concentration and increasing exposure, with an individual approach. Together with general clinical and laboratory examinations, we used international scales for assessing the severity of the patient condition by the Kupperman menopausal index (MMI), ESAS, quality of life (MOS-SF-36), in a modification of the Russian International Center, pain (VAS); the types of general adaptive reactions were identified by the method of L.Kh. Garkavi.

Results. Important advantages of a new method associated with a rapid regression of pathological psychosomatic symptoms were revealed after XT. MMI values (p<0.05) decreased, 96.8% of patients reported no pain at all on activity, manifestations of neurovegetative disorders significantly decreased (p=0.02–0.04), and the coefficient of antistress reactions to stress increased, which was congruent with the data on improving the quality of life. Conclusion. High efficiency of the technology demonstrated possible prevention of surgical menopause development and clinical manifestations of postcastration syndrome in order to improve the quality of life and social rehabilitation of young patients with gynecological cancers.

1. Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010 Dec 15;127(12):2893–2917. https://doi.org/10.1002/ijc.25516

2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492

3. Malignant neoplasms in Russia in 2016 (morbidity and mortality). Edited by Kaprin AD, Starinsky VV, Petrova GV. M., 2018. 250 p. (In Russian). Available at: https://docplayer.ru/68451567Zlokachestvennye-novoobrazovaniya-v-rossii-v-2016-godu.html

4. Aksel EM, Vinogradova NN. Statistics of malignant neoplasms of female reproductive organs. Gynecologic Oncology. 2018;(3 (27)):64–78. (In Russian).

5. Ashrafyan LA, Kiselev VI, Kuznetsov IN, Serova OF, Uzdenova ZKh, Gerfanova EV. Cervical cancer: problems of prevention and screening in the Russian Federation. Doktor.Ru. 2019;(11 (166)):50–54. (In Russian).

6. Mazitova MI, Antropova EYu, Mardieva RR. Postacute syndrome. Diary of the Kazan medical school. 2018;(1(19)):108–110. (In Russian).

7. Kolbasova EA, Kiseleva NI, Arestova IM, Kozhar ED, Yarotskaya NN. Content of stable products of nitrogen monoxide degradation in patients after surgical shutdown of ovarian function in the dynamics of the postoperative period. Achievements of fundomental, clinical medicine and pharmacy. 2015;(1):136–138. (In Russian).

8. Levine ME, Lu AT, Chen BH, Hernandez DG, Singleton AB, Ferrucci L, et al. Menopause accelerates biological aging. Proc Natl Acad Sci USA. 2016 16;113(33):9327–9332. https://doi.org/10.1073/pnas.1604558113

9. Dyachenko VG. Quality of life of breast cancer patients in the process of complex antitumor therapy. Bulletin of Public Health and Healthcare of the Russian Far East. 2016;(4 (25)):4. (In Russian).

10. Semiglazova TYu, Teletaeva GM, Kozyavin NA, Zagatina AV. Diagnosis and prevention of cardiotoxicity in patients with breast cancer from the standpoint of an oncologist and a cardiologist. Tumors of female reproductive system. 2017;13(3):17–27. (In Russian).

11. Khokhlova SV, Kolomiets LA, Kravets OA, Morkhov KYu, Nechushkina VM, Novikova EG, et al. Practical recommendations for the drug treatment of cervical cancer. Malignant tumors: Practical recommendations RUSSCO. 2018;8(3s2):178–189. (In Russian). https://doi.org/10.18027/2224–5057–2018–8–3s2–178–189

12. Kolbasova EA, Kiseleva NI, Arestova IM. Comparative clinical and hormonal characteristics of the state of health and quality of life of women with surgical and natural menopause. Vestnik of Vitebsk State Medical University. 2014;13(2):78–86. (In Russian).

13. Rocca WA, Grossardt BR, Shuster LT. Oophorectomy, Menopause, Estrogen Treatment, and Cognitive Aging: Clinical Evidence for a Window of Opportunity. Brain Research. 2011 Mar 16;1379:188–198. https://doi.org/10.1016/j.brainres.2010.10.031

14. Novikova EG, Kaprin AD, Trushina OI. An oncogynecologist's view of cervical cancer screening. Russian Bulletin of obstetrician-gynecologist. 2014;14(5):39–43. (In Russian).

15. Igoshina TV. Psychophysiological justification of the use of xenon inhalation method in the correction of neurotic, stressrelated disorders in persons of dangerous professions: Diss. … doctor of medical Sciences, Moscow, 2017, 25 p. (In Russian).

16. Churuksaeva ON, Kolomiets LA. Problems of quality of life of cancer patients. Questions of Oncology. 2017;63(3):368–374. (In Russian).

17. Corradetti B, Pisano S, Conlan RS, Ferrari M. Nanotechnology and Immunotherapy in Ovarian Cancer: Tracing New Landscapes. J Pharmacol Exp Ther. 2019;370(3):636–646. https://doi.org/10.1124/jpet.118.254979

18. Pokul LV. Natural and vegetative biologically active components: possibilities and perspectives for correcting dysfunction of the mammary glands in patients of reproductive age after total oophorectomy. Questions of Gynecology, Obstetrics and Perinatology. 2014;13(2):16–22. (In Russian).

19. Yarmolinskaya MI. Experience with micronized progesterone used in combined hormone therapy in periand postmenopausal women. Obstetrics and gynecology. 2014;(9):108–113. (In Russian).

20. Prokopieva TA, Napolskikh VM, Gorbunova EE. Quality of life as an efficiency criterion of hormone replacement therapy in rehabilitation program of patients with cervical cancer. Health, demography, ecology of Finno-Ugric peoples. 2016;(1):79–81. (In Russian).

21. Totchiev GF, Kotikova NP. Opportunities to overcome the negative consequences of climacteric syndrome. Gynecology. 2015;17(6.):11–13. (In Russian).

22. Dovgusha VV, Dovgusha LV. Physical mechanisms of the physiological and biological effects of inert gases on the body. St. Petersburg: Publishing House, 2012. (In Russian).

23. Nikolaev LL, Petrova MV, Bolikhova NA, Dobrovol'skaya NYu, Potapov AV. Xenon as a component of accompanying therapy during chemotherapy of patients with breast cancer. Effective Pharmacotherapy. 2014;(57):6–9. (In Russian).

24. Marx T, Schmidt M, Schirmer U, Reinelt H. Xenon as inhalation anaesthetic — Results from animal studies. Applied Cardiopulmonary Pathophysiology. 2000 Jan 1;9:124–128.

25. Garkavi LKh, Kvakina EB, Kuzmenko TS, Shikhlyarova AI. Antistress reactions and activation therapy. Activation reaction as a way to health through self-organization processes. Ekaterinburg. RIA "Philanthropist". 2002: Part 1, 2003: Part 2. (In Russian).

26. Vikhlyaeva E.M. Guide to endocrine gynecology. Moscow: MIA, 2000. (In Russian).

27. Huskisson EC. Measurement of pain. Lancet. 1974 Nov 9;2(7889): 1127–1131. https://doi.org/10.1016/s0140–6736(74)90884–8

28. Gerbershagen HJ, Aduckathil S, van Wijck AJM, Peelen LM, Kalkman CJ, Meissner W. Pain intensity on the first day after surgery: a prospective cohort study comparing 179 surgical procedures. Anesthesiology. 2013 Apr;118(4): 934–944. https://doi.org/10.1097/ALN.0b013e31828866b3